%0 Journal Article
%T Australasian recurrent pregnancy loss clinical management guideline 2024, part II.
%A Suker A
%A Li Y
%A Robson D
%A Marren A
%A  
%J Aust N Z J Obstet Gynaecol
%V 0
%N 0
%D 2024 Jun 27
%M 38934293
%F 1.884
%R 10.1111/ajo.13820
%X Part II of the Australasian guideline for the investigation and management of recurrent pregnancy loss (RPL) provides evidence-based guidance on the management of RPL provided. The implications of inherited and acquired thrombophilia with respect to RPL and suggestions for clinical management are provided. Autoimmune factors, including human leukocyte antigen, cytokines, antinuclear antibodies and coeliac antibodies, and guidance for management are discussed. Infective, inflammatory and endometrial causes of RPL are discussed in detail. Environmental and lifestyle factors, male factor and unexplained causes are outlined. Levels of evidence and grades of consensus are provided for all evidence-based statements.